טוען...
The steady progress of targeted therapies, promising advances for lung cancer
Lung cancer remains one of the most complex and challenging cancers, being responsible for almost a third of all cancer deaths. This grim picture seems however to be changing, for at least a subset of lung cancers. The number of patients who can benefit from targeted therapies is steadily increasing...
שמור ב:
| הוצא לאור ב: | Ecancermedicalscience |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cancer Intelligence
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4898931/ https://ncbi.nlm.nih.gov/pubmed/27350784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.638 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|